Increasing Insulin Pump Use in Youth with Type 1 Diabetes While Addressing Disparities
Related Experiment Video
Updated: Oct 31, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Kimberly K Vidmar1, Rachel J Fenske2, Whitney Beaton3
1From the Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Introduction:
Automated insulin delivery is recommended for youth with type 1 diabetes (T1D). We aimed to increase the percentage of youth with T1D (diagnosed > 1 y) in 1 pediatric health system actively using an insulin pump from 56% to 65% within 18 months while reducing disparities based on race/ethnicity and insurance type.
Methods:
Following the Model for Improvement, local stakeholders organized this quality improvement project, identified a theory of change, and tested change ideas using the plan-do-study-act framework. We evaluated the primary outcome with a statistical process control chart, secondary outcomes with run charts, and other measures with descriptive statistics.
Results:
Between February 2024 and August 2025, insulin pump use increased from 56% to 65%, but disparities by race/ethnicity and insurance type persisted. Time from insulin pump education to initiation decreased by 19.8 days for patients who attended a group technology class. Non-face-to-face encounter volume decreased from 938 to 862 encounters per month, and diabetes-associated ketoacidosis events remained stable at 2% per month.
Conclusions:
This initiative increased insulin pump use among both reference and minoritized groups of youth with T1D at a single institution and improved the efficiency of the insulin pump initiation process without a measurable increase in workload or diabetes-associated ketoacidosis events. Although increased pump adoption among both groups is encouraging, continued advocacy at the individual and policy levels is needed to achieve optimal pump use and reduce disparities.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations